Dimension 2 is expected to be the lower critical dimension for Anderson localization in a time-reversal-invariant disordered quantum system. Using an atomic quasiperiodic kicked rotor-equivalent to a two-dimensional Anderson-like model-we experimentally study Anderson localization in dimension 2 and we observe localized wave function dynamics. We also show that the localization length depends exponentially on the disorder strength and anisotropy and is in quantitative agreement with the predictions of the self-consistent theory for the 2D Anderson localization.
Anderson localization, the absence of diffusion in disordered media, draws its origins from the destructive interference between multiple scattering paths. The localization properties of disordered systems are expected to be dramatically sensitive to their symmetries. So far, this question has been little explored experimentally. Here we investigate the realization of an artificial gauge field in a synthetic (temporal) dimension of a disordered, periodically driven quantum system. Tuning the strength of this gauge field allows us to control the parity–time symmetry properties of the system, which we probe through the experimental observation of three symmetry-sensitive signatures of localization. The first two are the coherent backscattering, marker of weak localization, and the recently predicted coherent forward scattering, genuine interferential signature of Anderson localization. The third is the direct measurement of the β(g) scaling function in two different symmetry classes, allowing to demonstrate its universality and the one-parameter scaling hypothesis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.